DHSC’s Global AMR Innovation
Fund (GAMRIF) would like to share the details of the new round of funding
announced by CARB-X last week. CARB-X are one of GAMRIF’s delivery partners,
working to fill AMR product gaps in the global pipeline. This is a global call
with 4 product themes:
- THERAPEUTICS FOR INFECTIONS CAUSED BY GRAM-NEGATIVE PATHOGENS
- NOVEL APPROACHES TO PREVENTION FOR INVASIVE DISEASE
- DIAGNOSTICS FOR NEONATAL SEPSIS
- PROOF-OF-CONCEPT FOR NOVEL SAMPLE TYPES
FOR DIAGNOSING LOWER-RESPIRATORY-TRACT INFECTIONS
Further details on the call are available here: CARB-X
launches new funding round to fill major R&D gaps in global pipeline –
Carb-X
